Aadi Bioscience, Inc. (AADI) Reports In-Line Q3 EPS

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.46), in-line with the analyst estimate of ($0.46). Revenue for the quarter came in at $7.21 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Tenax Therapeutics (TENX) Reiterated at Overweight by Cantor Fitzgerald: Ph3 Data in Q3
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat